- 全部删除
您的购物车当前为空
BMY-14802 hydrochloride (BMS 181100 hydrochloride) 是一种选择性的 σ 受体拮抗剂 (IC50 = 112 nM),具有抗精神病作用。 BMY-14802 hydrochloride 是 α1-肾上腺素能受体和 5-HT1A 的激动剂。

BMY-14802 hydrochloride (BMS 181100 hydrochloride) 是一种选择性的 σ 受体拮抗剂 (IC50 = 112 nM),具有抗精神病作用。 BMY-14802 hydrochloride 是 α1-肾上腺素能受体和 5-HT1A 的激动剂。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 121 | In stock | |
| 5 mg | ¥ 305 | In stock | |
| 10 mg | ¥ 487 | In stock | |
| 25 mg | ¥ 1,010 | In stock | |
| 50 mg | ¥ 1,510 | In stock | |
| 100 mg | ¥ 2,190 | In stock | |
| 200 mg | ¥ 3,090 | In stock |
BMY-14802 hydrochloride 相关产品
| 产品描述 | BMY-14802 hydrochloride (BMS 181100 hydrochloride) is a selective antagonist of σ receptor (IC50 = 112 nM) with antipsychotic effects. BMY-14802 hydrochloride is an agonist of the α1-adrenergic receptor and 5-HT1A. |
| 靶点活性 | σ receptor:112 nM (IC50) |
| 体外活性 | BMY-14802 hydrochloride 对5-HT能和儿茶酚胺能神经元的放电有影响,并且以5-HT1A敏感的方式影响行为[3]。 |
| 体内活性 | 通过腹膜内给药,BMY-14802 hydrochloride(5-20 mg/kg)在4倍剂量范围内表现出对L-DOPA诱导的运动障碍具有抗病效果,同时不影响L-DOPA对损伤诱导的运动缺失的疗效。BMY-14802 hydrochloride能够减少D1和D2受体激动剂诱导的运动障碍[2]。 |
| 别名 | BMY-14802-1, BMY 14802 hydrochloride, BMS 181100 hydrochloride |
| 分子量 | 384.85 |
| 分子式 | C18H23ClF2N4O |
| CAS No. | 105565-55-7 |
| Smiles | Cl.OC(CCCN1CCN(CC1)c1ncc(F)cn1)c1ccc(F)cc1 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | H2O: 9.0 mg/mL (23.4 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
H2O
| ||||||||||||||||||||||||||
评论内容